Pro-inflammatory cytokine signaling network

The pro-inflammatory cytokine signaling network is a complex, interconnected system of signaling molecules and pathways that coordinate the body's inflammatory response (Dinarello, 2000, Chest). It primarily involves cytokines such as Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), which bind to specific cell-surface receptors to trigger downstream cascades like the NF-kappaB and JAK/STAT pathways (O'Shea et al., 2013, NEJM). While essential for host defense against pathogens and tissue repair, dysregulation of this network leads to chronic inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis (Feldmann & Maini, 2003, Nature Medicine). Therapeutic intervention typically focuses on specific nodes within the network, such as monoclonal antibodies that neutralize cytokines or small molecules that inhibit intracellular signaling kinases (Schett et al., 2013, Nature Reviews Rheumatology). Over-activation of this network can also lead to life-threatening conditions like cytokine release syndrome or cytokine storms seen in severe infections (Singh et al., 2015, Arthritis & Rheumatology).

Other names

Inflammatory cytokine cascadePro-inflammatory signaling pathwayCytokine networkInflammatory milieu

Inhibition of specific cytokine ligands, blockade of cytokine receptors, or inhibition of downstream intracellular signaling cascades (e.g., JAK inhibition).